![Thomas Balzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Balzer
Chief Tech/Sci/R&D Officer at
LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC.
Net worth: - $ as of 2026-08-30
Profile
Thomas Balzer is currently Chief Medical Officer & SVP-Clinical Development at Lakewood-Amedex Biotherapeutics, Inc. since 2023.
Formerly, Dr. Balzer was Vice President at Bayer U.S.
LLC.
Education includes a doctorate from Freie Universität Berlin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-29 | 0 ( -.--% ) | - $ | 2026-08-30 |
Thomas Balzer active positions
| Companies | Position | Start |
|---|---|---|
| LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-31 |
Former positions of Thomas Balzer
| Companies | Position | End |
|---|---|---|
Bayer U.S. LLC
 Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Corporate Officer/Principal | - |
Training of Thomas Balzer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
 Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Bayer U.S. LLC
Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
- Stock Market
- Insiders
- Thomas Balzer
